Costs of Air Pollution in California's San Joaquin Valley: A Societal Perspective of the Burden of Asthma on Emergency Departments and Inpatient Care
Gilda Zarate-Gonzalez,Paul Brown,Ricardo Cisneros
DOI: https://doi.org/10.2147/jaa.s455745
2024-04-18
Journal of Asthma and Allergy
Abstract:Gilda Zarate-Gonzalez, Paul Brown, Ricardo Cisneros Department of Public Health, University of California, Merced, CA, USA Correspondence: Gilda Zarate-Gonzalez, Department of Public Health, University of California, Merced, 5200 N Lake Road, Merced, CA, 95343, USA, Tel + 1 559-269-3609, Email Introduction: The San Joaquin Valley (SJV) is often recognized as one of the most polluted regions in the US. Periods of pollution exposure are associated with increased health burden related to respiratory inflammation and undermined lung function, which aggravates respiratory diseases such as asthma and leads to symptoms such as coughing, wheezing, or difficulty breathing. Asthma costs US&dollar 82 billion annually in healthcare costs, missed work and school in the US. Methods: Employing a societal perspective, a cost of illness design was combined with environmental epidemiological methods to analyze the economic impact of O 3 , NO 2 , and PM 2.5 -related adverse respiratory health outcomes amongst SJV residents who attended the emergency department (ED) or were hospitalized in 2016. Results: Asthma exacerbations monetized value ranged from US&dollar 3353 to US&dollar 5003 per ED visit and for hospital admissions US&dollar 2584 per inpatient day for adults 65 years and older to US&dollar 3023 per child. The estimated value to society in healthcare costs, productivity losses, school absences, and opportunity costs from air pollution adverse health outcomes totaled US&dollar 498,014,124 in ED visits and US&dollar 223,552,720 in hospital admissions for the SJV population in 2016. The marginal reduction in the background concentrations of pollutants would avert 21,786 ED adverse events and 19,328 hospitalizations from the health burden on the SJV population or US&dollar 8,024,505 cost savings due to O 3 , US&dollar 82,482,683 from NO 2 reductions, and US&dollar 46,214,702 from decreased concentration of PM 2.5 . Conclusion: This study provides evidence that air pollution is a negative externality that imposes substantial social, environmental, and healthcare costs on the SJV. Furthermore, the region would avert significant adverse health outcomes realizing economic savings by reducing air pollution and exposures. Keywords: health economics, air pollution, asthma, cost of illness, public health Compelling scientific literature has demonstrated the detrimental effects on human health of primary and secondary anthropogenic ambient air pollution: nitrogen dioxide (NO 2 ), particulate matter (PM 2.5 ), and ground-level ozone (O 3 ). 1–3 Children, adolescents, the elderly, and patients with cardiopulmonary diseases are particularly at risk of the deleterious effects of exposure to concentrations of criteria pollutants. 4,5 Periods of pollution exposure are associated with increased health burden related to respiratory inflammation and undermined lung function, which aggravates respiratory diseases such as asthma and leads to symptoms such as coughing, wheezing, or difficulty breathing. 6 Furthermore, the US Environmental Protection Agency (EPA) has recognized that human exposure to air pollutants, such as particular matter and ground-level ozone, are likely causes of asthma and respiratory infections. 7 In the US asthma costs $82 billion annually in healthcare costs, missed work, and school absences. 8 In other developed countries respiratory diseases account for 52 million DALY losses per year, a conservatively estimated value of $317 billion in healthcare costs, lost productivity, and disability. 9 By 2050, global health-related costs from ozone exposure will be estimated to reach $580 billion. 10 In just one region of India, economic losses due to PM 2.5 pollution were valued at US$ 2.2 billion in 2013. 11 NO 2 has been deemed the "most harmful" of all nitrogen oxide compounds that humans are exposed to daily, 12 and the National Health Service (NHS) of England has estimated that by 2025, NO 2 will cost US$ 3.29 billion in healthcare and social costs for childhood asthma, coronary heart disease, stroke, and lung cancer. 13 The health and economic evidence of the impact of air pollution has been accumulating over time from studies worldwide. Existing research has examined the significant costs associated with exposure to particulate matter (PM) air pollution in France and Lebanon. 14,15 These studies accounted for 135 million francs in medical care, pharmaceuticals, x-rays, and labs for one million residents living near a power plant who suffered asthma exacerbations, bronchitis, -Abstract Truncated-
immunology,allergy,respiratory system